Obesity and hypertension: epidemiological and clinical issues
- PMID: 3301356
- DOI: 10.1093/eurheartj/8.suppl_b.57
Obesity and hypertension: epidemiological and clinical issues
Abstract
The relationship between obesity and hypertension has been investigated in a large number of cross-sectional population studies and a smaller number of prospective, observational studies. The results indicate that in most populations, blood pressure increases linearly with increasing body weight or body mass index. The relationship is present across all subgroups, although the magnitude of the association appears greater in whites than blacks and greater in younger than older persons. It is estimated that as much as one-third of all hypertension may be attributable to obesity in populations where hypertension and obesity are widely prevalent. Evidence from prospective studies and clinical trials suggests that hypertension in obese patients increases the risk of cardiovascular disease and that drug treatment of hypertension reduces the risk. However, it is uncertain whether the risks associated with hypertension and the benefits of treatment are as great in obese hypertensives as they are in lean hypertensives. The effects of weight reduction on blood pressure have been investigated in a small number of randomized, controlled trials involving a total of about 600 participants. Overall, the results of the trials indicate that weight reduction lowers blood pressure over intervals of up to one year. The magnitude of the blood pressure response appears to be directly proportional to the amount of weight loss achieved. However, the latter is inversely related to the length of follow-up. Adequate maintenance of weight loss remains a major problem for the much-needed, long-term trials of the effects of weight reduction on blood pressure and the cardiovascular complications of hypertension.
Similar articles
-
[Obesity and hypertension].G Ital Cardiol (Rome). 2008 Apr;9(4 Suppl 1):54S-59S. G Ital Cardiol (Rome). 2008. PMID: 18773751 Italian.
-
[Pharmacological therapy of obesity].G Ital Cardiol (Rome). 2008 Apr;9(4 Suppl 1):83S-93S. G Ital Cardiol (Rome). 2008. PMID: 18773755 Italian.
-
Obesity and hypertension: cardiovascular response of weight reduction.Hypertension. 1982 Sep-Oct;4(5 Pt 2):III50-5. doi: 10.1161/01.hyp.4.5_pt_2.iii50. Hypertension. 1982. PMID: 7049931 Review.
-
The treatment of hypertension in obese patients.Curr Hypertens Rep. 2008 Apr;10(2):143-50. doi: 10.1007/s11906-008-0027-9. Curr Hypertens Rep. 2008. PMID: 18474182 Review.
-
Hypertension in obesity.Nutr Metab Cardiovasc Dis. 2001 Oct;11(5):344-53. Nutr Metab Cardiovasc Dis. 2001. PMID: 11887431 Review.
Cited by
-
Associations of diabetes, hypertension and obesity with COVID-19 mortality: a systematic review and meta-analysis.BMJ Glob Health. 2023 Dec 14;8(12):e012581. doi: 10.1136/bmjgh-2023-012581. BMJ Glob Health. 2023. PMID: 38097276 Free PMC article.
-
The causal effect of air pollution on the risk of essential hypertension: a Mendelian randomization study.Front Public Health. 2024 Feb 15;12:1247149. doi: 10.3389/fpubh.2024.1247149. eCollection 2024. Front Public Health. 2024. PMID: 38425468 Free PMC article.
-
Characteristics of changes in plasma proteome profiling after sleeve gastrectomy.Front Endocrinol (Lausanne). 2024 Feb 5;15:1330139. doi: 10.3389/fendo.2024.1330139. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38375199 Free PMC article.
-
Effect of Physical Activity on Metabolic Syndrome Markers in Adults with Type 2 Diabetes: A Systematic Review and Meta-Analysis.Sports (Basel). 2023 May 9;11(5):101. doi: 10.3390/sports11050101. Sports (Basel). 2023. PMID: 37234057 Free PMC article. Review.
-
An estimating equation approach to dimension reduction for longitudinal data.Biometrika. 2016 Mar;103(1):189-203. doi: 10.1093/biomet/asv066. Epub 2016 Feb 16. Biometrika. 2016. PMID: 27017956 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical